Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06829394Recruiting

Transitional Housing and HIV Health

Role: collaborator

NCT04951310Not ApplicableCompleted

COVID-19 Vaccinations With a Sweepstakes

Role: collaborator

NCT03908437Phase 4Completed

Rapid Initiation of Drug Treatment Engagement

Role: collaborator

NCT02390245Not ApplicableCompleted

Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

Role: collaborator

NCT02693145Not ApplicableCompleted

Cooperative Re-Engagement Controlled Trial (CoRECT)

Role: collaborator

NCT03637465Not ApplicableCompleted

Increasing Water Access and Appeal in Community Recreation Centers

Role: lead

All 6 trials loaded